Radiation Therapy Alone Compared to Radiation Therapy Plus Chemotherapy in Treating Patients With Previously Untreated Cancer of the Nasopharynx
NCT00003637 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 200
Last updated 2013-12-19
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether radiation therapy alone is more effective than radiation therapy plus chemotherapy in treating cancer of the nasopharynx.
PURPOSE: This randomized phase III trial is studying how well radiation therapy and chemotherapy works compared to radiation therapy alone in treating patients with previously untreated cancer of the nasopharynx.
Conditions
Interventions
- DRUG
- DRUG
- RADIATION
-
radiation therapy
Sponsors & Collaborators
-
National Cancer Centre, Singapore
lead OTHER
Principal Investigators
-
Eu J. Chua, MD · National Cancer Centre, Singapore
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1998-09-30
Countries
- Singapore
Study Locations
More Related Trials
-
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
NCT00052429 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
S9715, Chemotherapy and Radiation Therapy in Treating Patients With Advanced Cancer of the Nasopharynx
NCT00002999 ·Status: WITHDRAWN ·Phase: PHASE2
-
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx
NCT00025298 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
NCT00274937 ·Status: COMPLETED ·Phase: PHASE3
-
Induction Versus Adjuvant Gemcitabine/Cisplatin in Locally Advanced Non-metastatic Nasopharyngeal Carcinoma
NCT04898374 ·Status: RECRUITING ·Phase: PHASE3
-
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT00002476 ·Status: COMPLETED ·Phase: PHASE3
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx
NCT00004094 ·Status: UNKNOWN ·Phase: PHASE2
-
High-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With Head and Neck Cancer
NCT00002555 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00005088 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Larynx or Oropharynx Cancer
NCT00014118 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer
NCT05050162 ·Status: SUSPENDED ·Phase: PHASE2/PHASE3
-
The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma
NCT01187238 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)
NCT00896181 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Stage II or Stage III Oropharyngeal Cancer
NCT00006360 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced and/or Recurrent Head and Neck Cancer
NCT00004097 ·Status: UNKNOWN ·Phase: PHASE1
-
Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx
NCT04538547 ·Status: UNKNOWN ·Phase: NA
-
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
NCT00408694 ·Status: COMPLETED ·Phase: PHASE2
-
Concurrent Cisplatin Chemoradiation With or Without Capecitabine as Adjuvant Chemotherapy in Local Advanced High Risk Nasopharyngeal Carcinoma: Randomized Control Clinical Trial
NCT02143388 ·Status: COMPLETED ·Phase: PHASE3
-
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
NCT02734537 ·Status: RECRUITING ·Phase: PHASE2
-
Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma
NCT02301208 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiation Therapy With or Without Cisplatin in Treating Patients With Advanced Head and Neck Cancer
NCT00002654 ·Status: COMPLETED ·Phase: PHASE3
-
GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma
NCT06490341 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
NCT06136962 ·Status: NOT_YET_RECRUITING
-
Radiation Therapy, Combination Chemotherapy, and Amifostine in Treating Patients With Head and Neck Cancer
NCT00003582 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer
NCT00608205 ·Status: COMPLETED ·Phase: PHASE3